PHIL
发表于 2025-3-25 04:08:24
http://reply.papertrans.cn/11/1007/100670/100670_21.png
cumulative
发表于 2025-3-25 10:31:14
978-3-540-43884-7Springer-Verlag Berlin Heidelberg 2003
Resection
发表于 2025-3-25 13:55:47
http://reply.papertrans.cn/11/1007/100670/100670_23.png
雪白
发表于 2025-3-25 16:34:43
http://reply.papertrans.cn/11/1007/100670/100670_24.png
Inordinate
发表于 2025-3-25 21:09:04
Vijay K. Madisetti,Chonlameth Arpikanondtint bleedings and hemophilic arthropathy in hemophilia patients, a long-term prophylactic therapy with factor VIII or IX concentrates has been suggested. This coagulation factor substitution can be complicated by the development of antibodies against factor VIII or IX (sc. inhibitors).
magenta
发表于 2025-3-26 01:02:04
Monetary and Financial RequirementsEach year the Institute of Social Medicine of Vienna (ISM) organizes the annual survey of the Austrian Hemophilia Centers where the anonymous questionnaires from all collaborating centers are collected and analyzed.
愉快么
发表于 2025-3-26 06:29:26
http://reply.papertrans.cn/11/1007/100670/100670_27.png
衍生
发表于 2025-3-26 12:21:20
http://reply.papertrans.cn/11/1007/100670/100670_28.png
Canvas
发表于 2025-3-26 12:49:59
http://reply.papertrans.cn/11/1007/100670/100670_29.png
Adulterate
发表于 2025-3-26 19:00:06
Platform-Centric SoC Design Methodology,rinolysis predispose to thromboembolic events . The factor V (FV) G1691A Mutation and the prothrombin (Fil) G20210A variant appear to be relevant not only in adult thromboembolism. However, due to the low incidence of thromboembolic events in childhood, the role of hereditary prothrombotic risk